Literature DB >> 30560774

Schistosoma japonicum-Associated Colorectal Cancer: A Review.

Hytham K S Hamid1.   

Abstract

Schistosoma japonicum is a digenetic blood fluke that has been implicated in the carcinogenesis of several human malignancies, notably liver and colorectal cancer (CRC). Schistosoma japonicum-associated colorectal cancer (SACC) is a distinct subtype with biological behavior analogous to colitis-induced CRC. The clinicopathological characteristics of SACC include young age at diagnosis, predominance among males, a strong predilection for the sigmoid colon and rectum, multifocal distribution, frequent mucinous histology, and poor prognosis. In addition to chronic inflammation, immunomodulation, and schistosomal toxins, bacterial coinfection appears to play an important role in the carcinogenic process. The present review provides the most recent updates on epidemiology, pathobiology, and clinical and prognostic features pertaining to SACC.

Entities:  

Mesh:

Year:  2019        PMID: 30560774      PMCID: PMC6402928          DOI: 10.4269/ajtmh.18-0807

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  16 in total

1.  Relationship between salt-inducible kinase 2 (SIK2) and lymph node metastasis in colorectal cancer patients complicated with chronic schistosomiasis.

Authors:  Chao Wu; Yu Wang; Hongliang Gao; Yi Zhang; Min Dai; Shu Li
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-10-25

Review 2.  The Road to Elimination: Current State of Schistosomiasis Research and Progress Towards the End Game.

Authors:  Paul Ogongo; Ruth K Nyakundi; Gerald K Chege; Lucy Ochola
Journal:  Front Immunol       Date:  2022-05-03       Impact factor: 8.786

3.  Is schistosomiasis japonica a negative short-term or long-term prognostic factor in patients with acute appendicitis?

Authors:  Hytham K S Hamid
Journal:  Jpn J Radiol       Date:  2020-02-15       Impact factor: 2.374

4.  Colorectal Schistosomiasis Infection After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Metastatic Colon Adenocarcinoma: A Case Report.

Authors:  Sulaiman Alshammari; Ashwaq Almajed; Retaj Alkhawaja; Turki Alshammari; Riyadh Hakami; Sufia Husain; Thamer Bin Traiki
Journal:  Am J Case Rep       Date:  2021-05-11

5.  Comparison of non-schistosomal colorectal cancer and schistosomal colorectal cancer.

Authors:  Weixia Wang; Kui Lu; Limei Wang; Hongyan Jing; Weiyu Pan; Sinian Huang; Yanchao Xu; Dacheng Bu; Meihong Cheng; Jing Liu; Jican Liu; Weidong Shen; Yingyi Zhang; Junxia Yao; Ting Zhu
Journal:  World J Surg Oncol       Date:  2020-07-01       Impact factor: 2.754

Review 6.  Employing Parasite Against Cancer: A Lesson From the Canine Tapeworm Echinococcus Granulocus.

Authors:  Wang Guan; Xiaoqin Zhang; Xiao Wang; Shun Lu; Jun Yin; Jinxin Zhang
Journal:  Front Pharmacol       Date:  2019-09-25       Impact factor: 5.810

7.  Pancreatic Leiomyosarcoma With Schistosomiasis Hematobia: A Case Report and Literature Review.

Authors:  Qiang Li; Daniel Staiculescu; Yurong Zhou; Jiang Chen
Journal:  Front Oncol       Date:  2021-03-31       Impact factor: 6.244

8.  The clinical features of chronic intestinal schistosomiasis-related intestinal lesions.

Authors:  Xian Qin; Cai-Yuan Liu; Yi-Lin Xiong; Tao Bai; Lei Zhang; Xiao-Hua Hou; Jun Song
Journal:  BMC Gastroenterol       Date:  2021-01-06       Impact factor: 3.067

9.  Schistosoma japonicum SjE16.7 Protein Promotes Tumor Development via the Receptor for Advanced Glycation End Products (RAGE).

Authors:  Chenyun Wu; Xinyue Du; Lili Tang; Jianhua Wu; Wei Zhao; Xiaokui Guo; Dengyu Liu; Wei Hu; Helena Helmby; Guangjie Chen; Zhaojun Wang
Journal:  Front Immunol       Date:  2020-08-21       Impact factor: 7.561

10.  Comparison of the clinicopathological features and prognoses of patients with schistosomal and nonschistosomal colorectal cancer.

Authors:  Zijian Wang; Zhixiang Du; Yinhua Liu; Wenjie Wang; Manman Liang; Aiping Zhang; Jianghua Yang
Journal:  Oncol Lett       Date:  2020-01-22       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.